Folgen
Subhendu Mukherjee
Subhendu Mukherjee
Senior Group Leader at Aurigene Oncology Ltd.
Bestätigte E-Mail-Adresse bei aurigene.com
Titel
Zitiert von
Zitiert von
Jahr
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan, SE Carson, ...
Nature 601 (7893), 434-439, 2022
1272022
Protein kinase inhibitors
T Linnanen, G Wohlfahrt, S Nanduri, R Ujjinamatada, S Rajagopalan, ...
US Patent 9,447,091, 2016
422016
Discovery of CA-4948, an orally bioavailable IRAK4 inhibitor for treatment of hematologic malignancies
VR Gummadi, A Boruah, BR Ainan, BR Vare, S Manda, HP Gondle, ...
ACS Medicinal Chemistry Letters 11 (12), 2374-2381, 2020
392020
Discovery of pyridyl bis (oxy) dibenzimidamide derivatives as selective matriptase inhibitors
R Goswami, S Mukherjee, G Wohlfahrt, C Ghadiyaram, J Nagaraj, ...
ACS medicinal chemistry letters 4 (12), 1152-1157, 2013
322013
Indazole and azaindazole compounds as irak-4 inhibitors
VR Gummadi, S Samajdar, S Mukherjee
US Patent App. 15/744,448, 2018
282018
QSAR of estrogen receptor modulators: exploring selectivity requirements for ERα versus ERβ binding of tetrahydroisoquinoline derivatives using E-state and physicochemical …
S Mukherjee, A Saha, K Roy
Bioorganic & medicinal chemistry letters 15 (4), 957-961, 2005
282005
Substituted Aza Compounds as IRAK-4 Inhibitors
VR Gummadi, S Samajdar, S Mukherjee, MG Bock
US Patent App. 15/744,451, 2018
272018
Structure-guided discovery of 1, 3, 5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy
R Goswami, S Mukherjee, C Ghadiyaram, G Wohlfahrt, RK Sistla, ...
Bioorganic & medicinal chemistry 22 (12), 3187-3203, 2014
272014
3-Alkoxy-pyrrolo[1,2-b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration
T Ullrich, S Sasmal, V Boorgu, S Pasagadi, S Cheera, S Rajagopalan, ...
Journal of Medicinal Chemistry 57 (17), 7396-7411, 2014
262014
ODM-203, a selective inhibitor of FGFR and VEGFR, shows strong antitumor activity, and induces antitumor immunity
TH Holmström, AM Moilanen, T Ikonen, ML Björkman, T Linnanen, ...
Molecular Cancer Therapeutics 18 (1), 28-38, 2019
242019
QSAR modeling on binding affinity of diverse estrogenic flavonoids: electronic, topological and spatial functions in quantitative approximation
S Mukherjee, A Mukherjee, A Saha
Journal of Molecular Structure: Theochem 715 (1-3), 85-90, 2005
222005
QSAR studies with E-state index: predicting pharmacophore signals for estrogen receptor binding affinity of triphenylacrylonitriles
S Mukherjee, A Mukherjee, A Saha
Biological and Pharmaceutical Bulletin 28 (1), 154-157, 2005
212005
Pharmacophore mapping of selective binding affinity of estrogen modulators through classical and space modeling approaches: Exploration of bridged-cyclic compounds with …
S Mukherjee, S Nagar, S Mullick, A Mukherjee, A Saha
Journal of chemical information and modeling 47 (2), 475-487, 2007
182007
Pharmacophore mapping of arylbenzothiophene derivatives for MCF cell inhibition using classical and 3D space modeling approaches
S Mukherjee, S Nagar, S Mullick, A Mukherjee, A Saha
Journal of Molecular Graphics and Modelling 26 (5), 884-892, 2008
172008
Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach
R Goswami, G Wohlfahrt, S Mukherjee, C Ghadiyaram, J Nagaraj, ...
Bioorganic & medicinal chemistry letters 25 (3), 616-620, 2015
162015
Reproductive effects of ethnomedicinal formulation of tape-vine leaves in female rats
S Mukherjee, R Banerjee, SN Upadhyay, J Hazra, KN Poddar, ...
Biological and Pharmaceutical Bulletin 29 (9), 1916-1922, 2006
162006
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors
R Goswami, G Wohlfahrt, O Törmäkangas, A Moilanen, ...
Bioorganic & Medicinal Chemistry Letters 25 (22), 5309-5314, 2015
152015
Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders
A Bhumireddy, NVMR Bandaru, BR Reddy, ST Gore, S Mukherjee, ...
Bioorganic & Medicinal Chemistry Letters 55, 128448, 2022
132022
Spiro [cyclobutane-1, 3′-indolin]-2′-one Derivatives as Bromodomain Inhibitors
RK Ujjinamatada, S Samajdar, C Abbineni, S Mukherjee, T Linnanen, ...
US Patent 10,336,697, 2019
132019
Pyrazolo [1, 5-A][1, 3, 5] triazine and pyrazolo [1, 5-A] pyrimidine derivatives as CDK inhibitors
S Samajdar, R Poddutoori, S Mukherjee, R Goswami
US Patent 11,186,576, 2021
112021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20